- Oops!Something went wrong.Please try again later.
Vancouver, British Columbia--(Newsfile Corp. - July 15, 2021) - Tracesafe Inc. (CSE: TSF) ("TraceSafe"), a global leader in wearable safety tech and connected workforce solutions, including large-scale venue management and asset tracking, announced today that it will be the exclusive provider of wearable health and safety technology for the Calgary Stampede from July 9 - 18.
TraceSafe's wearable technology, in the form of ultra-light battery-powered wristbands, will be used by all competition athletes, rodeo staff, and international travellers. Calgary Stampede officials worked in consultation with leading event professionals, the Alberta health authorities, and TraceSafe to develop a discreet technology solution that will allow the event to proceed safely.
"We're excited to work with the Calgary Stampede Organization and Alberta health authorities again as they oversee a successful and safe Calgary Stampede this year," said Susanne MacKillop, VP Sales at TraceSafe. "As the event organizers worked with their local health authorities it was clear adding TraceSafe's wearable technology supported the additional measures required for this year's event."
This deployment follows TraceSafe's successes in other popular event venues, like Boston's TD Gardens and at the World Junior Hockey Championship earlier this year.
"Operating safely is the primary focus of Stampede, and we continue to work closely with key health partners to assure the safety of our competitors and our community. Utilizing TraceSafe products is just one of the many ways we are meeting and exceeding safety guidelines for Stampede 2022," said Brett Warder, Manager of Agriculture & Western Events Operations at Calgary Stampede.
TraceSafe is a full suite of real-time location management services and contact tracing solutions enabled through advanced low-power Bluetooth beacons and enterprise cloud management. TraceSafe's leading cloud management solution ensures both user privacy and comprehensive administrative control. TraceSafe's patented contact tracing bracelet has already been deployed in mission-critical quarantine applications around the world in partnership with leading governments. In addition to their government work, TraceSafe is developing leading-edge solutions for Enterprise, Healthcare, Education, Government, and large-scale venue management.
For further information, please contact:
Wayne Lloyd, CEO
+1 (604) 629-9975
Emily Graham, CFO
+1 (604) 356-8111
The Canadian Securities Exchange has in no way approved or disapproved the contents of this news release.
Statements in this news release may contain forward-looking statements that are based on TraceSafe's expectations, estimates and projections regarding its business and the economic environment in which it operates, including with respect to expectations regarding the TraceSafe assets and their application, future business plans and relationships, future developments in respect of COVID-19 and solutions adopted in response to the virus, and the deployment and acceptance of the TraceSafe technology. Although TraceSafe believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict, including the suitability of our products to help businesses and governments reopen, competition, the spread or containment of COVID-19 and government responses thereto and general economic and market conditions. Therefore, outcomes and results may differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date on which they are made, and TraceSafe undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances unless otherwise required to do so by law.
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/90252